Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41591-022-01789-0
PubMed Identifier: 35589854
Publication URI: http://europepmc.org/abstract/MED/35589854
Type: Journal Article/Review
Volume: 28
Parent Publication: Nature medicine
Issue: 6
ISSN: 1078-8956